Peptide agonists of GLP-1 activity
US6528486B1 · kind B1 · utility
172Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2000 |
| Grant date | Mar 4, 2003 |
| Priority date | — |
| Expiry date | Jul 12, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.